Preliminary Safety, Efficacy and Molecular Characterization in Patients with Higher-Risk Myelodysplastic Syndrome Treated with…
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide
Read Article
Sequential Therapy…
Abstract C095: [212Pb]VMT-a-NET for somatostatin receptor subtype 2 (SSTR2)-expressing tumors: safety and preliminary efficacy…
ACE-BREAST-03: A phase 2 trial evaluating ARX788, an anti-HER2 antibody drug conjugate (ADC), for…
Purpose • Innovation • Relationship • Excellence
© 2025 Nebraska Cancer Specialists • Privacy Policy • design by Chip Thompson
Meet DOT.